Top

Published in:

01-01-2019 | Original Article

The impact of automated screening with Edmonton Symptom Assessment System (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients

Authors: Benjamin D. Diplock, Kaitlin M. C. McGarragle, Willem A. Mueller, Sana Haddad, Rachel Ehrlich, Dong-Hyun A. Yoon, Xingshan Cao, Yaseen Al-Allaq, Paul Karanicolas, Margaret I. Fitch, Jeff Myers, Alex J. Mitchell, Janet W. M. Ellis

Published in: Supportive Care in Cancer | Issue 1/2019

Abstract

Purpose

We aimed to assess the impact of implementing Edmonton Symptom Assessment System (ESAS) screening on health-related quality of life (HRQoL) and patient satisfaction with care (PSC) in ambulatory oncology patients. ESAS is now a standard of care in Ontario cancer centers, with the goal of improving symptom management in cancer patients, yet few studies examine impact of ESAS on patient outcomes.

Methods

We compared ambulatory oncology patients who were not screened prior to ESAS site implementation (2011–2012), to a similar group who were screened using ESAS after site implementation (2012–2013), to examine between-group differences in patient HRQoL, PSC outcomes, and supportive care needs (Supportive Care Service Survey). Both no-ESAS (n = 160) and ESAS (n = 108) groups completed these measures: the latter completing them, along with ESAS, at baseline and 2 weeks later.

Results

After assessing the impact of implementing ESAS, by matching for potentially confounding variables and conducting univariate analyses, no significant between-group differences were found in HRQoL or PSC. There was significant improvement in symptoms of nausea/vomiting and constipation, after 2 weeks. Lower symptom burden with decreased ESAS scores was significantly correlated with increased HRQoL. There were no between-group differences in knowledge of/access to supportive care.

Conclusions

Significant correlation between change in ESAS and HRQoL implies ESAS could usefully inform healthcare providers about need to respond to changes in symptom and functioning between visits. This study showed no impact of early-ESAS screening on HRQoL or PSC. Further research should explore how to better utilize ESAS screening, to improve communication, symptom management, and HRQoL.

Available only for authorised users

Advisory CCSs, Statistics CoC (2015) Canadian Cancer Statistics 2015 Special topic: predictions of the future burden of cancer in Canada. Canadian Cancer Society, Toronto

Stein KD, Syrjala KL, Andrykowski MA (2008) Physical and psychological long-term and late effects of cancer. Cancer 112(11 Suppl):2577–2592. https://doi.org/10.1002/cncr.23448 CrossRefPubMed

Mitchell AJ, Ferguson DW, Gill J, Paul J, Symonds P (2013) Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol 14(8):721–732. https://doi.org/10.1016/S1470-2045(13)70244-4 CrossRef

Polsky D, Doshi JA, Marcus S, Oslin D, Rothbard A, Thomas N, Thompson CL (2005) Long-term risk for depressive symptoms after a medical diagnosis. Arch Intern Med 165(11):1260–1266. https://doi.org/10.1001/archinte.165.11.1260 CrossRefPubMed

Steel JL, Geller DA, Gamblin TC, Olek MC, Carr BI (2007) Depression, immunity, and survival in patients with hepatobiliary carcinoma. J Clin Oncol 25(17):2397–2405CrossRefPubMed

Ganz PA, Kwan L, Stanton AL, Krupnick JL, Rowland JH, Meyerowitz BE, Bower JE, Belin TR (2004) Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst 96(5):376–387CrossRefPubMed

Massie MJ (2004) Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 2004(32):57–71. https://doi.org/10.1093/jncimonographs/lgh014 CrossRef

Carlson LE, Waller A, Mitchell AJ (2012) Screening for distress and unmet needs in patients with cancer: review and recommendations. J Clin Oncol 30(11):1160–1177. https://doi.org/10.1200/JCO.2011.39.5509 CrossRefPubMed

Carlson LE, Bultz BD (2003) Cancer distress screening. Needs, models, and methods. J Psychosom Res 55(5):403–409CrossRefPubMed

10.

Moghaddam N, Coxon H, Nabarro S, Hardy B, Cox K (2016) Unmet care needs in people living with advanced cancer: a systematic review. Support Care Cancer 24(8):3609–3622. https://doi.org/10.1007/s00520-016-3221-3 CrossRefPubMed

11.

Fitch M (2000) Supportive care for cancer patients. Hosp Q 3(4):39–46PubMed

12.

Vignaroli E, Pace EA, Willey J, Palmer JL, Zhang T, Bruera E (2006) The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med 9(2):296–303. https://doi.org/10.1089/jpm.2006.9.296 CrossRefPubMed

13.

Patient experience with outpatient care (2016) Cancer Care Ontario. http://www.csqi.on.ca/cms/One.aspx?portalId=351209&pageId=354730

14.

Bultz BD, Waller A, Cullum J, Jones P, Halland J, Groff SL, Leckie C, Shirt L, Blanchard S, Lau H, Easaw J, Fassbender K, Carlson LE (2013) Implementing routine screening for distress, the sixth vital sign, for patients with head and neck and neurologic cancers. J Natl Compr Cancer Netw 11(10):1249–1261CrossRef

15.

Mitchell AJ (2013) Screening for cancer-related distress: when is implementation successful and when is it unsuccessful? Acta Oncol 52(2):216–224. https://doi.org/10.3109/0284186X.2012.745949 CrossRefPubMed

16.

Chang VT, Hwang SS, Feuerman M (2000) Validation of the Edmonton Symptom Assessment Scale. Cancer 88(9):2164–2171CrossRefPubMed

17.

Rees E, Hardy J, Ling J, Broadley K, A'Hern R (1998) The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK. Palliat Med 12(2):75–82. https://doi.org/10.1191/026921698674135173 CrossRefPubMed

18.

Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9PubMed

19.

Dudgeon D, King S, Howell D, Green E, Gilbert J, Hughes E, Lalonde B, Angus H, Sawka C (2012) Cancer Care Ontario’s experience with implementation of routine physical and psychological symptom distress screening. Psychooncology 21(4):357–364. https://doi.org/10.1002/pon.1918 CrossRefPubMed

20.

Howell D, Molloy S, Wilkinson K, Green E, Orchard K, Wang K, Liberty J (2015) Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Annals of Oncology Advance Access Published April at Massachusetts General Hospital Treadwell Library on, 17. Retrieved from http://annonc.oxfordjournals.org/

21.

Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J, Hull JG, Li Z, Tosteson TD, Byock IR (2009) Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA 302(7):741–749CrossRefPubMedPubMedCentral

22.

Street RL, Makoul G, Arora NK, Epstein RM (2009) How does communication heal? Pathways linking clinician–patient communication to health outcomes. Patient Educ Couns 74(3):295–301CrossRefPubMed

23.

Epstein RM, Street JR RL (2007) Patient-centered communication in cancer care: promoting healing and reducing suffering. NIH Publication No. 07-6225. National Cancer Institute, Bethesda

24.

Winefield HR, Murrell TG, Clifford J (1995) Process and outcomes in general practice consultations: problems in defining high quality care. Soc Sci Med 41(7):969–975CrossRefPubMed

25.

Manary MP, Boulding W, Staelin R, Glickman SW (2013) The patient experience and health outcomes. N Engl J Med 368(3):201–203CrossRefPubMed

26.

Richardson LA, Jones GW (2009) A review of the reliability and validity of the Edmonton Symptom Assessment System. Curr Oncol 16(1):55PubMedPubMedCentral

27.

Nekolaichuk C, Watanabe S, Beaumont C (2008) The Edmonton Symptom Assessment System: a 15-year retrospective review of validation studies (1991–2006). Palliat Med 22(2):111–122. https://doi.org/10.1177/0269216307087659 CrossRefPubMed

28.

Garyali A, Palmer JL, Yennurajalingam S, Zhang T, Pace EA, Bruera E (2006) Errors in symptom intensity self-assessment by patients receiving outpatient palliative care. J Palliat Med 9(5):1059–1065CrossRefPubMed

29.

Bagha S, Macedo A, Jacks L, Lo C, Zimmermann C, Rodin G, Li M (2013) The utility of the Edmonton Symptom Assessment System in screening for anxiety and depression. Eur J Cancer Care 22(1):60–69CrossRef

30.

Watanabe SM, Nekolaichuk CL, Beaumont C (2012) The Edmonton Symptom Assessment System, a proposed tool for distress screening in cancer patients: development and refinement. Psychooncology 21(9):977–985. https://doi.org/10.1002/pon.1996 CrossRefPubMed

31.

Watanabe S, Nekolaichuk C, Beaumont C, Mawani A (2009) The Edmonton symptom assessment system—what do patients think? Support Care Cancer 17(6):675–683CrossRefPubMed

32.

Gilbert JE, Howell D, King S, Sawka C, Hughes E, Angus H, Dudgeon D (2012) Quality improvement in cancer symptom assessment and control: the Provincial Palliative Care Integration Project (PPCIP). J Pain Symptom Manag 43(4):663–678. https://doi.org/10.1016/j.jpainsymman.2011.04.028 CrossRef

33.

Davison SN, Jhangri GS, Johnson JA (2006) Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients. Nephrol Dial Transplant 21(11):3189–3195CrossRefPubMed

34.

Ringdal GI, Ringdal K (1993) Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses. Qual Life Res 2(2):129–140CrossRefPubMed

35.

Loblaw DA, Bezjak A, Singh PM, Gotowiec A, Joubert D, Mah K, Devins GM (2004) Psychometric refinement of an outpatient, visit-specific satisfaction with doctor questionnaire. Psychooncology 13(4):223–234. https://doi.org/10.1002/pon.715 CrossRefPubMed

36.

Loblaw DA, Bezjak A, Bunston T (1999) Development and testing of a visit-specific patient satisfaction questionnaire: the Princess Margaret Hospital Satisfaction With Doctor Questionnaire. J Clin Oncol 17(6):1931–1938. https://doi.org/10.1200/JCO.1999.17.6.1931 CrossRefPubMed

37.

Poinsot R, Altmeyer A, Conroy T, Savignoni A, Asselain B, Leonard I, Marx E, Cosquer M, Sevellec M, Gledhill J, Rodary C, Mercier M, Dickes P, Fabbro M, Antoine P, Guerif S, Schraub S, Dolbeault S, Bredart A (2006) Multisite validation study of questionnaire assessing out-patient satisfaction with care questionnaire in ambulatory chemotherapy or radiotherapy treatment. Bull Cancer 93(3):315–327PubMed

38.

Bernard R (2010) Fundamentals of Biostatistics (7th ed). Thomson-Brooks/ Cole. https://doi.org/10.1002/bimj.4710350205

39.

Database OCSMR (2010) Symptom severity for patients with all typers of cancer, all reporting regional cancer centres, 2015

40.

Nguyen TV, Bosset JF, Monnier A, Fournier J, Perrin V, Baumann C, Bredart A, Mercier M (2011) Determinants of patient satisfaction in ambulatory oncology: a cross sectional study based on the OUT-PATSAT35 questionnaire. BMC Cancer 11:526. https://doi.org/10.1186/1471-2407-11-526 CrossRefPubMedPubMedCentral

41.

Bergh I, Kvalem IL, Aass N, Hjermstad MJ (2011) What does the answer mean? A qualitative study of how palliative cancer patients interpret and respond to the Edmonton Symptom Assessment System. Palliat Med 25(7):716–724. https://doi.org/10.1177/0269216310395985 CrossRefPubMed

42.

Watanabe S, McKinnon S, Macmillan K, Hanson J (2006) Palliative care nurses’ perceptions of the Edmonton Symptom Assessment Scale: a pilot survey. Int J Palliat Nurs 12(3):111–114. https://doi.org/10.12968/ijpn.2006.12.3.20694 CrossRefPubMed

43.

Gill A, Daines P, Selby D (2010) What do symptom scores mean: observations on discrepancies when defining symptoms using words and numbers. Eur J Oncol Nurs 14(5):435–438CrossRefPubMed

44.

Williams LA, Garcia Gonzalez AG, Ault P, Mendoza TR, Sailors ML, Williams JL, Huang F, Nazha A, Kantarjian HM, Cleeland CS, Cortes JE (2013) Measuring the symptom burden associated with the treatment of chronic myeloid leukemia. Blood 122(5):641–647. https://doi.org/10.1182/blood-2013-01-477687 CrossRefPubMedPubMedCentral

45.

Carr AJ, Higginson IJ (2001) Are quality of life measures patient centred? BMJ 322(7298):1357–1360CrossRefPubMedPubMedCentral

Title: The impact of automated screening with Edmonton Symptom Assessment System (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients
Authors: Benjamin D. Diplock
Kaitlin M. C. McGarragle
Willem A. Mueller
Sana Haddad
Rachel Ehrlich
Dong-Hyun A. Yoon
Xingshan Cao
Yaseen Al-Allaq
Paul Karanicolas
Margaret I. Fitch
Jeff Myers
Alex J. Mitchell
Janet W. M. Ellis
Publication date: 01-01-2019
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 1/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-018-4304-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2019

Nausea in advanced cancer: relationships between intensity, burden, and the need for help

ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients

Effectiveness of peer support on health-related quality of life in recently diagnosed breast cancer patients: a randomized controlled trial

Couples’ symptom burden in oncology care: perception of self and the other

Levels of unmet needs among adolescents and young adults (AYAs) impacted by parental cancer

Ambivalence over emotional expression and physical functioning and limitations: mediating and moderating effects of PTSD symptoms and acculturation among Chinese breast cancer survivors

Keynote webinar | Spotlight on antibody–drug conjugates in cancer